Precio de cierre
Otros sitios de cotización
|
||
- SEK | - |
2023 | Synokem Pharmaceuticals Limited adquirió a Recipharm AB (publ) una participación del 74% en Nitin Lifesciences Limited. | CI |
2023 | Recipharm anuncia cambios en su CEO | CI |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Grégory Behar
CEO | Chief Executive Officer | 55 | 01/01 |
Director of Finance/CFO | - | 03/04/23 | |
Ulrike Lemke
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Luc Burgard
COO | Chief Operating Officer | 43 | - |
Marc Funk
BRD | Director/Board Member | 64 | 01/01/21 |
Human Resources Officer | - | - | |
Kieran Chouhan
PRN | Corporate Officer/Principal | - | 01/02/19 |
Bernard Pluta
PRN | Corporate Officer/Principal | - | 01/10/15 |
Shabbir Mostafa
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 60 | 01/06/15 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Steven Klosk
BRD | Director/Board Member | 67 | 01/03/21 |
Director/Board Member | 67 | 01/01/21 | |
Richard Ridinger
CHM | Chairman | 66 | 01/03/21 |
Marc Funk
BRD | Director/Board Member | 64 | 01/01/21 |
Director/Board Member | 43 | 01/03/21 | |
Henrik Giver
BRD | Director/Board Member | 35 | 01/01/21 |
Director/Board Member | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 370 000 | 0 | 0 | 56,25 % |
Acción B | 10 | 21 312 000 | 0 | 0 | |
Acción C | 1 | 79 803 683 | 57 089 305 ( 71,54 %) | 0 |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Recipharm Ltd.
Recipharm Ltd. Pharmaceuticals: MajorHealth Technology Recipharm Ltd. manufactures pharmaceutical products. It offers branded and generic products. The company was founded on August 10, 2012 and is headquartered in Ashton-under-Lyne, the United Kingdom. |
Pharmaceuticals: Major
|
Recipharm Venture Fund AB
Recipharm Venture Fund AB Investment ManagersFinance Recipharm Venture Fund AB is a venture capital fund that makes strategic investments in start-ups and biotechnology companies that are seen as important to Recipharm's business. The fund invests in both private and public companies. |
Investment Managers
|
Recipharm Holdings Ltd.
Recipharm Holdings Ltd. MiscellaneousMiscellaneous Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom. |
Miscellaneous
|
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,85 % | 74,45 mil M | |
+11,24 % | 9180,02 M | |
-12,85 % | 5021,85 M | |
+60,16 % | 5030,08 M | |
+1,60 % | 3820,27 M | |
-19,20 % | 2409,95 M | |
+18,65 % | 2391,59 M | |
+24,62 % | 2262,33 M | |
-27,46 % | 2274,04 M |
- Bolsa de valores
- Acciones
- Acción RECI B
- Acción
- Empresa Recipharm publ AB